From Merck & Co to Sanofi, Pharmaceutical Technology lists the leading pharmaceutical companies spending the most on R&D in ...

AstraZeneca has maintained that while the vaccine may, in “very rare” cases, cause TTS, the casual mechanism for this effect ...

Emergent also said it will shut down two of its US-based complexes – a drug substance manufacturing facility in Baltimore and ...

Janssen-Cilag has sought expanded European Medicines Agency (EMA) approval for TREMFYA to treat active ulcerative colitis and ...

Bayer and Evotec have expanded collaboration to focus on the development of precision treatments for cardiovascular diseases ...

The updated identity is part of international sweeping changes by J&J as the big pharma unites its medtech and pharmaceutical ...

The FDA has awarded the designation following a review of initial safety and efficacy data from two Phase I/II clinical trials.

Dengue fever is now found in over 120 countries compared to nine that experienced severe epidemics in the 1970s given the ...

UK liquid biopsy company, Angle, has agreed a supplier agreement with AstraZeneca to develop a Parsotix-based Androgen Receptor (AR) assay for use in prostate cancer studies.

The NHS in the UK has announced plans to offer Pfizer's Voxelotor (Oxbryta), a new treatment option for sickle cell disease.

Amgen ’s total revenues grew in Q1 2024 to $7.4bn, displaying a 22% increase from earnings reported in the first quarter of last year.

Eli Lilly has announced that its net income rose to $2.24bn in Q1 2024, a 67% increase from $1.34bn in the same period of ...